AEGiS-VOA: Why Monkeys Resist AIDS

Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.

Why Monkeys Resist AIDS

Voice of America - February 26, 2004
Jessica Berman
Washington

Dr. Joseph Sodroski,
Dana-Farber Cancer Institute

Monkeys do not become sick with AIDS. Now some scientists say they have discovered why. They have identified a key protein that makes monkeys resistant to the disease. The finding could be an invaluable tool for studying the deadly virus, possibly leading to better treatments and even a cure. The protein is called trim-5-alpha and, once AIDS has been injected into rhesus monkeys, trim-5-alpha thwarts H-I-V infection by refusing to relay the virus' genetic instructions to its D-N-A, triggering the process that leads to AIDS.

Right now, much research is focused on the later stages of H-I-V infection, once the virus has commandeered the body's immune system. The research has led to combination therapies that keep the disease at bay.

But finding trim-5-alpha could give researchers a tool to attack the disease at an earlier stage, before it really gets started. Virologist Joseph Sodroski of the Dana-Farber Cancer Institute in Boston oversaw the research that pinpointed trim-5-alpha as the primary agent in rhesus monkeys that causes resistance to AIDS.

"It's been observed over the years that H-I-V can enter monkey cells, but once they enter those cells, it encounters a very specific and potent block."

Dr. Sodroski says humans also have genes that make trim-5-alpha, but at much lower levels.

"I think there's going to be many people thinking of creative ways to try to potentiate the human factor, and stimulate our own natural resistance to H-I-V."

Cellular biologist Stephen Goff of Columbia University in New York says the discovery of trim-5-alpha, by shining light on the earliest stages of the AIDS process, could eventually lead to drugs that interrupt the transformation of human HIV into AIDs.

"The most exciting potential is that this will tell us how to attack the virus at a novel stage, really a stage that would be very attractive to target, where we just haven't had enough information on how to proceed."

Professor Goff's comments on the discovery of trim-5-alpha is published in the journal Nature, where the research appears.

Reference

Stremlau M, Owens CM, Perron MJ, et al., "The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.", Nature. 2004 Feb 26;427(6977):848-53

PubMED Related articles Search

040226
VA040211

Copyright © 2004 - Voice of America. You are welcome to use any material that is published by voanews.com, or you may link to any of the web pages that Voice of America has published on the internet. There is no need to request further permission. Should you wish to establish a link to any VOA web pages, please send your request to pubaff@ibb.gov. We would appreciate that credit for any use of VOA material be given to voanews.com, Voice of America, or VOA, and we ask that you not abridge or edit any VOA material which you may use.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, the National Library of Medicine, Bridgestone Firestone Trust Fund, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .